Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Surface-modified bioresorbable electrospun scaffolds for improving hemocompatibility of vascular grafts.

Caracciolo PC., Rial-Hermida MI., Montini-Ballarin F., Abraham GA., Concheiro A., Alvarez-Lorenzo C.

Laboratory Study on Face & Skin, published in Mater Sci Eng C Mater Biol Appl (2017) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Mater Sci Eng C Mater Biol Appl (2017)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
28415397
DOI
10.1016/j.msec.2017.02.151
Citations
25

Abstract (original English)

The replacement of small-diameter vessels is one of the main challenges in tissue engineering. Moreover, the surface modification of small-diameter vascular grafts (SDVG) is a key factor in the success of the therapy due to their increased thrombogenicity and infection susceptibility caused by the lack of a functional endothelium. In this work, electrospun scaffolds were prepared from blends of poly(L-lactic acid) (PLLA) and segmented polyurethane (PHD) with a composition designed to perform as SDVG inner layer. The scaffolds were then successfully surface-modified with heparin following two different strategies that rely on grafting of heparin to either PLLA or PHD functional groups. Both strategies afforded high heparin density, being higher for urethane methodology. The functionalized scaffolds did not cause hemolysis and inhibited platelet adhesion to a large extent. However, lysozyme/heparin-functionalized scaffolds obtained through urethane methodology achieved the highest platelet attachment inhibition. The increase in hydrophilicity and water absorption of the surface-functionalized nanostructures favored adhesion and proliferation of human adipose-derived stem cells. Heparinized surfaces conjugated with lysozyme presented microbial hydrolysis activity dependent on heparin content. Overall, a better performance obtained for urethane-modified scaffold, added to the fact

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Absorbable ImplantsBlood PlateletsBlood Vessel ProsthesisCoated Materials, BiocompatibleHeparinHumansMuramidasePlatelet AdhesivenessPolyestersPolyurethanes

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research